Uninsured in St. Louis: a script for asking about Spravato
Asking a doctor about a treatment is hard enough. Asking about one you just learned the name of, while also knowing that you will be paying for every minute of the visit yourself, adds a second layer of pressure. You want to use the time well. You also want to leave knowing what it will cost.
This script is for people in St. Louis without health insurance who want to ask a clinician about esketamine, the nasal spray marketed as Spravato, for depression that standard medication has not relieved.
Why you may need to raise it yourself
In June 2026 our publisher commissioned a survey of 443 Midwest adults. Of every hundred, 73 said they had never heard of Spravato, and only 6 knew what it actually was. The remaining 21 percent recognized the name without knowing what it did. These numbers are final. The 39 uninsured respondents were even less familiar: 85 percent had never heard of it.
The awareness gap cuts both ways. Patients rarely know to ask, and a busy clinician at a walk-in or sliding-scale clinic may not think of it for someone who has not been seen before. Meanwhile, a doctor's opinion is the thing people trust most. Seventy-four percent of respondents named their own doctor's recommendation as what would get them to try a treatment like this. If you want that opinion, the fastest route is to ask for it.
Where to have the conversation in St. Louis
No regular doctor? Federally funded health centers across St. Louis city and county base their fees on income. Many include behavioral health services. You can find locations by ZIP code at findahealthcenter.hrsa.gov. Community mental health programs and certified clinics around St. Louis also see people with or without insurance.
Before you go, take ten minutes to check whether you qualify for MO HealthNet. Missouri's Medicaid expansion opened coverage to many working-age adults, and people turned down years ago sometimes qualify now. If you are covered, your costs and your options change significantly.
What to bring
- Your antidepressant history on paper: names, doses, and how long each lasted
- Any records from past mental health care, if you have them
- Your current medications and health conditions, including blood pressure
- This script, on paper or in your phone
The script
Open with the history.
"I've been dealing with depression for [length of time]. I've tried these medicines, and they haven't worked well enough. Here's the list."
Esketamine's approval is for adults whose depression outlasted two or more antidepressants, so that history sits at the center of any eligibility question.
Say that you are paying yourself.
"I don't have insurance right now, so cost matters a lot to me. I want to understand my options and what they would cost."
This is not an awkward admission. It helps the clinician recommend options you can actually use, and it invites them to mention sliding-scale programs or assistance you did not know about.
Ask about esketamine directly.
"I read about esketamine, the nasal spray called Spravato. Would I be a candidate for it? If not, why not?"
Ask about the difference from ketamine offers you have seen.
"I've also seen ads for ketamine infusions and at-home ketamine. How are those different from esketamine, and would you recommend any of them for me?"
A good clinician will explain that esketamine holds an FDA approval for stubborn depression and is administered only in certified settings with observation, while IV and at-home ketamine for depression are off-label. Hearing that from someone who knows your health is worth the visit. To read up beforehand, try this plain Spravato overview.
Ask about money and assistance.
"If esketamine makes sense, do you know of a treatment center in St. Louis that works with uninsured patients? Is there a manufacturer assistance program I should apply for?"
Ask about cheaper steps first.
"Is there anything else I should try first that might cost less, like a different medication or therapy through a sliding-scale program?"
This question keeps the conversation honest. Sometimes the next right step is a less expensive one, and a clinician will tell you so when invited.
Close with next steps.
"What should I do next, and is there someone at this clinic who can help me with coverage or assistance paperwork?"
What you might hear back
You may hear that esketamine is a reasonable option, and that you should talk to a certified center about cost and assistance. You may hear that you are not yet a candidate because you have not tried enough medications at full doses. You may hear that a health issue makes it a poor fit. Each is a valid clinical answer. Ask what would need to change for esketamine to be reconsidered, and when to follow up.
The practical side of a yes
If a clinician refers you, remember what the treatment involves. Sessions are twice a week at first, then less often. Each session includes at least two hours of monitoring. Driving waits until after you have slept, so someone will need to take you home. Ask the center for a written estimate covering a full course rather than a single session.
In our survey, a slim majority of respondents would take insurance coverage with extra hoops over paying for a simpler start, while 23 percent preferred to pay themselves. If you are paying, that 23 percent is your company. It is still worth asking a caseworker or clinic navigator whether coverage is within reach before you commit.
If depression and money pressure have pushed you toward thoughts of suicide, please do not wait for any appointment. The Suicide and Crisis Lifeline at 988 is open all hours by call or text, free, with no insurance needed; veterans can press 1.
Methodology
We conducted the survey on Pollfish's consumer panel, and it stayed open until June 23, 2026, by which point 443 adults aged 18 to 64 had taken it, from Nebraska, Missouri, Iowa, Kansas, Oklahoma, Wisconsin, Ohio, Indiana, Minnesota, and Illinois. We report whole-sample figures plus the uninsured breakdown, with no city-level cut, and every figure has been validated as final. The study was requested and funded by the publisher.